drugset / Trial / NCT02868697

Management of Tunneled Catheter Thrombosis in Hemodialysis Patients: Prospective Study From Qatar

NCT02868697

Phase 4 Completed 170 enrolled Hamad Medical Corporation
RandomizedParallel-groupSingle-blindTreatment

Summary

Goal of the study: A- To find out the best protocol for catheter lock solution to decrease the prevalence of catheter thrombosis 1. \- The time to first episode of catheter thrombosis lead to catheter change. 2. \- Number of acute episode of thrombosis that interrupt dialysis 3. \- Median Survival life of the catheter in both groups after adjusting it to the outcome. B- Specific Objective: To evaluate the cost effectiveness by measure 1- Amount of r-TPA used in each group to treatment acute catheter thrombosis 2- Number of catheter exchange in both group 3- Hospitalization days related to catheter malfunctioning or CRI in each group 4- Type and days of antibiotics 5- Cost of the treatment in each group c- Secondary Objective: To correlate the result of two catheters lock solution protocols with the published data using r-TPA instead of heparin once week as compared with heparin 3 times per week as a locking solution.

Timeline

Start
2013-11
Primary completion
2015-08
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Heparin Other / unclassified 500 unknown Other
Subject Urokinase Protein / enzyme biologic 25000 iu Other
Background citrate Unknown 4 % Other
Comparator taurolidine Small molecule 1.35 % Other

Indications

No indication recorded.